GENEVA, March 13 — Head of the World Health Organisation (WHO) said on Friday that the Geneva-based United Nations health agency "systematically reviews safety signals, and is carefully assessing the current reports on the AstraZeneca vaccine." The Covid-19 vaccine developed by AstraZeneca and...

JAKARTA, March 8 — Indonesia's state-owned pharmaceutical company Bio Farma said that 1.1 million doses of vaccine produced by AstraZeneca under the global vaccine-sharing Covax facility would arrive on Monday.

KUALA LUMPUR, March 3 — The first batch delivery of AstraZeneca Covid-19 vaccine, to Malaysia is expected to arrive in the second quarter of this year, said the pharmaceutical company.

KUALA LUMPUR, Feb 24 — The National Covid-19 Immunisation Programme is expected to be completed before the end of this year, ahead of its projected completion date in February next year.

NEW DELHI, Jan 2 — India has approved the Covid-19 vaccine developed by AstraZeneca and Oxford University, paving the way for a huge immunisation campaign in the world's second most populous country.

JAKARTA, Jan 1 — Indonesia received its second batch of coronavirus vaccines from Sinovac on Thursday, the country's Foreign and Health Ministers said, as the world's fourth most populous country prepares a mass inoculation programme.

LONDON, Dec 30 — Britain on Wednesday became the first country in the world to approve a coronavirus vaccine developed by Oxford University and AstraZeneca as it battles a major winter surge driven by a new, highly contagious variant of the virus.

KUALA LUMPUR, Dec 22 — The government has just signed an agreement with pharmaceutical company AstraZeneca for the procurement of an additional 10 per cent or 6.4 million doses of the Covid-19 vaccine, Prime Minister Tan Sri Muhyiddin Yassin announced.

KLUANG, Dec 20 — The government will be concluding an agreement with AstraZeneca of United Kingdom on Monday to purchase Covid-19 vaccine to meet the immunisation needs of 20 per cent of the people in the country.

MOSCOW, Nov 23 — The AZD1222 Covid-19 vaccine, developed by the Oxford University and the AstraZeneca pharmaceutical giant, is up to 90 per cent effective, according to results of an interim analysis of the clinical trials in the United Kingdom and Brazil, AstraZeneca said on Monday, noting that the average efficacy is assessed at 70 per cent.

KUALA LUMPUR, Sept 15 — The optimism over vaccine has continued to bolster the pharmaceutical counters with Duopharma and Pharmaniaga emerging among the top gainers.

ZURICH/FRANKFURT, Sept 10 — AstraZeneca's should still know before the end of the year whether its experimental vaccine protects people against Covid-19, the drugmaker's chief executive Pascal Soriot said on Thursday, as long as it can resume trials soon.